You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: study of central nervous system inflammation roots, circulating immune cells in cancer reflect patient response to treatment, and more.
The Bay Area startup is offering a no-touch method to separate cell populations for downstream analysis in genomics and synthetic biology applications.
RNA-seq of ascites from ovarian cancer patients uncovered shared inflammatory programs and suggested a JAK/STAT pathway inhibitor has antitumor activity.
BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.
In Nature this week: a fluorescence in situ hybridization-based method for multiplex RNA imaging, benchmark dataset for structural variants, and more.
In PNAS this week: features linked to coronavirus pathogenicity, multi-system syndrome linked to RNA modification-linked mutations, and more.
The firms are targeting a compatible offering for single-cell gene expression screens following CRISPR-based editing, with applications in drug discovery.
In Nucleic Acids Research this week: a web platform that combines large molecular and clinical datasets, a web resource for standardized single-cell RNA sequencing data, and more.
In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.
Harvard Medical School researchers developed a model that attributes the range of meiotic phenotypes to the effects of chromosome compaction.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.